MedTrace Logo

Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

NCT02852265 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-12-28

Study results available
· View outcomes & findings →

Summary

Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.

Conditions

  • Contraception

Interventions

DRUG

Etonogestrel contraceptive implant

Place nexplanon

Sponsors & Collaborators

Principal Investigators

  • Mitchell Creinin, MD · Univeristy of California, Davis

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-15
Primary Completion
2017-07-26
Completion
2017-07-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852265 on ClinicalTrials.gov